Based on the automated and continuous past three months acquisition of anemia treatment characteristics, patient-specific data, and laboratory parameters, ANN has the power to predict Hb concentrations 3 months into the future with high degree of accuracy. The gene discussed is GSTM1; the disease is anemia (phenotype).